PharmaSense: A Predictive Model for Estimating Drug Responses

Abstract

Predictive modeling for drug response constitutes a cornerstone of modern personalized medicine and drug discovery, leveraging machine learning (ML) and artificial intelligence (AI) to analyze large-scale biological datasets. Crucially, these multi-modal datasets integrate information like chemical properties of drugs, enabling computational models to efficiently discern subtle, complex patterns correlating biological features with drug outcomes. Unlike traditional, limited, and costly experimental methods, these ML-trained systems can predict drug behavior—such as adverse reactions, drug–drug interactions, or resistance patterns—on previously unseen samples. Beyond research and clinical trials, such models enable rapid, personalized drug interaction checks by incorporating individual patient information including age, gender, allergies, genetic markers, and current medications. This supports accurate, real-time decision-making in everyday healthcare settings, helping clinicians and patients avoid harmful interactions while selecting safer and more effective treatments. Consequently, this capability is paramount to the goal of precision medicine, facilitating the development and use of optimized, targeted therapies that improve patient outcomes while minimizing adverse side effects.

Keywords